IDEXX Laboratories Exec Says ~1/4th Of Cancerdx Orders In Q3 Came From Non-Primary Reference Lab Customers; Covet Rev Run Rate Is About $20M Annualized, Growing At Strong Double-Digit Rates

Benzinga · 2d ago

https://event.webcasts.com/starthere.jsp?ei=1778007&tp_key=2e8c83027b